Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction

Abstract

The findings in this study identify potential therapeutics [i.e. N2 peptide or 21G6 F(ab')(2)] that prevent specific IgM binding to ischaemic antigens in the heart, resulting in a significant reduction in cardiac I/R injury.